Davis Polk advised Leerink Swann LLC as the sole book-running manager in connection with an SEC-registered offering of 1,780,000 shares of common stock of Cardiovascular Systems, Inc. (CSI). The gross proceeds from the offering were approximately $16 million.

CSI is a medical device company focused on developing and commercializing innovative interventional treatment for vascular disease, including peripheral artery disease and coronary artery disease. CSI is headquartered in St. Paul, MN.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Sara Chang and Jeffrey C. Lau. Associates David R. Bauer and Daniel Ray provided intellectual property advice. Associate Catherine L. Martin provided 1940 Act advice. Counsel Marcie A. Goldstein provided FINRA advice. Partner Rachel D. Kleinberg and associate Una Au provided tax advice. Elizabeth J. Gordon, Haniya H. Mir and Nam Kim were the legal assistants on the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.



Related Posts:

Leave a Reply